Hyperthyroidism and thyrotoxicosis

Thyrotoxicosis or hyperthyroxinaemia is the state where the level of circulating free T3 and T4 is elevated, causing hypermetabolism. It is most commonly caused by hyperthyroidism, which is the state where the thyroid is overactive, but it can also be caused by ectopic hormones or destruction of the thyroid. Because of this, the two terms are often used interchangeably.

Etiology

Thyrotoxicosis can be caused by many conditions:

• Primary hyperthyroidism
  • Graves disease
  • Toxic adenoma
  • Toxic multinodular goiter
• Destruction of the thyroid gland – causes release of stored thyroid hormone in the early phase of disease
  • Hashimoto thyroiditis
  • De Quervain thyroiditis
  • Postpartum thyroiditis
  • Drug and contrast-induced thyroiditis (amiodarone, contrast material)
• Secondary hyperthyroidism
  • Gestational thyrotoxicosis – hCG stimulates TSH receptors due to their structural similarity
  • Struma ovarii – an ovarian teratoma which produces thyroxine
  • TSH-producing pituitary adenoma

In regions without iodine deficiency, Graves disease is the most common cause of thyrotoxicosis. In iodine deficient regions, toxic adenoma and toxic multinodular goitre are more common.

Clinical features

Thyrotoxicosis can cause many symptoms, most of which are related to the hypermetabolic state and to the overactivity of the sympathetic nervous system:

• Weight loss despite increased appetite
• Warm, moist skin
• Tachycardia or arrhythmia
• Heat intolerance
• Palmar erythema
• Nervousness
• Diarrhoea
• Hypertension with widened pulse pressure
• Palpitations
• Fine tremor
• Anxiety, restlessness

Diagnosis and evaluation

The diagnosis of (primary) hyperthyroidism is based on the levels of TSH, the most sensitive biomarker. Free T4 and T3 are measured to look for subclinical hyperthyroidism.

	TSH	Free T4	Free T3
Euthyroidism	Normal	Normal	Normal
Subclinical hyperthyroidism	Decreased	Normal	Normal
Overt hyperthyroidism	Decreased	Increased	Increased

The clinical features, including the thyroid size, consistency, nodularity, as well as the presence of eye symptoms, can help narrow the differential diagnosis. The following investigations are important in determining the etiology:

• Autoantibodies against thyroid peroxidase (anti-TPO), thyroglobulin (anti-Tg), and TSH receptor (anti-TSHR)
• Ultrasound
• Thyroid scintigraphy (nuclear imaging)

Treatment

Specific treatment depends on the underlying etiology, but supportive treatment is also available. Beta blockers can be used, of which propranolol is the first choice as it inhibits conversion of T3 to T4. Benzodiazepines may also be used in very short courses for anxiety.